The ADC binds HER2 on target cells, is internalized, and enzymatic linker cleavage releases a topoisomerase I inhibitor payload that blocks DNA replication, causing DNA damage, cell-cycle arrest, and apoptosis (with possible additional HER2 signaling inhibition).